SCHEMBL25922969

SCHEMBL25922969

CBc1ccc(O)cc1C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1I2 O75469 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ MIF P14174 1/20 0.41
▸ TYR P14679 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ NFE2L2 Q16236 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ KIF11 P52732 2/20 0.39
▸ AR P10275 4/20 0.39
▸ HSD17B3 P37058 1/20 0.38
▸ HSD17B1 P14061 2/20 0.36
▸ HSD17B2 P37059 2/20 0.36
▸ APP P05067 1/20 0.36
▸ TNIK Q9UKE5 1/20 0.34
▸ ESRRG P62508 1/20 0.34
▸ ESR2 Q92731 1/20 0.33
▸ NQO2 P16083 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14434929 0.78 IDO1 (0.42) AR
SCHEMBL3022860 0.73 KIF11 (0.52) NR1I2ALDH1A1LMNACYP2C9MIF
SCHEMBL30368360 0.73 KIF11 (0.52) NR1I2ALDH1A1LMNACYP2C9MIF
SCHEMBL257926 0.72 ESR1 (0.41) MIFARESR2ADRA2AADRA2B
SCHEMBL10034978 0.72 NR1I2 (0.45) NR1I2ALDH1A1LMNACYP2C9MIF
SCHEMBL29427019 0.72 NR1I2 (0.45) NR1I2ALDH1A1LMNACYP2C9MIF
SCHEMBL30595362 0.72 ALDH1A1 (0.60) NR1I2ALDH1A1LMNACYP2C9MIF
SCHEMBL5792355 0.72 GLA (0.54) NR1I2ALDH1A1LMNACYP2C9MIF
SCHEMBL31256038 0.72 GLA (0.54) NR1I2ALDH1A1LMNACYP2C9MIF
SCHEMBL5511642 0.72 ALDH1A1 (0.60) NR1I2ALDH1A1LMNACYP2C9MIF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141432-A2 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS, INC. (US) 2023-07-27 — — WO disclosed
Send feedback